Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment

J. J. Ley-Tomas, A. M. Xicotencatl-Tellez, M. L. García-Cruz, M. A. Jiménez-Chobillon · 2024

Read Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment by J. J. Ley-Tomas, A. M. Xicotencatl-Tellez, M. L. García-Cruz, M. A. Jiménez-Chobillon (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11631927.txt.

Description

Ley-Tomas and three co-authors review NSAID-exacerbated respiratory disease, its mechanisms, care and treatment, in work from 2024. The syndrome combines asthma, chronic rhinosinusitis with nasal polyps, and intolerance to aspirin and similar drugs. It may affect many people in the United States, and many cases need a provocation test to confirm.

The disease rests on an imbalance in the arachidonic acid pathway, and it tends to be severe even with full standard care. Polyps in the sinuses are often aggressive and return. New monoclonal antibodies that cut type 2 inflammation show strong promise for control, the authors report. The review gathers recent proof on causes, diagnosis and therapy choices.

Catalog record

CREATORJ. J. Ley-Tomas, A. M. Xicotencatl-Tellez, M. L. García-Cruz, M. A. Jiménez-Chobillon
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11631927

Browse the full library · About the Tower of Babel